Hakan Calhanoglu
CDM
Calhanoglu
CM
PAC
SHO
PAS
DRI
DEF
PHY
90
92
97
95
90
87
38,500
-2,804 (-6.79%)
Updated: 7 min ago
39,000 39,000 40,000PR% 51
PR: 11,500 - 75,000
View Sold Prices
Evolutions
PlaystylesHakan Calhanoglu 94 TOTS In Game Stats
PAC
AcceleRATE
Mostly Explosive
SHO
PAS
DRI
DEF
PHY
Total Face Stats551
Total Stats2,668
PlayStyles+
Long Ball Pass
Lob and Lofted Through Passes are more accurate, travel faster and are more difficult to intercept.
Anticipate
Improved chances of standing tackle success and grants the ability to stop the ball directly at their feet when performing a standing tackle.
Trivela
Contextually triggers outside of the foot passes and shots.
PlayStyles
Finesse Shot
Performs finesse shots faster with additional curve and improved accuracy.
Dead Ball
Set pieces are delivered with increased speed, curve and accuracy.Ball trajectory preview line is longer.
Intercept
Increased reach and improved chances of retaining possession of the ball when performing interceptions.
Bruiser
Greater strength when performing physical tackles.
First Touch
Has reduced error when trapping the ball and is able to transition to dribbling faster with greater control.
Aerial
Performs higher jumps and has improved aerial physical presence.
90
CB
94
CDM
94
CM
94
CAM
94
CF
90
ST
94
LW
94
RW
94
LM
94
RM
93
RB
94
RWB
93
LB
94
LWB
Hakan Calhanoglu 94 TOTS Price Graphs
Lowest Sale
Highest Sale
Average BIN
Last Sales
Average Auction
Last Sales
This item is Hakan Calhanoglu TOTS , a CDM from Turkey, playing in Serie A TIM. Calhanoglu FC 24 is 30 years old and has 5* skills and 4* weakfoot, and is Right footed. Calhanoglu's price on the xbox market is 38,500 coins (7 min ago), playstation is 0 coins (Never ago) and pc is 35,000 coins (1 hrs ago). There are 4 other versions of Hakan Calhanoglu in EA FC 24, check them out using the navigation above.
Report Comment
Please confirm you want to report the comment and your reason why you are reporting it.
If you simply disagree with the comment, please don't report it.
The comment has been successfully reported.
Comments